Pharmacovigilance Market Application Development, Price Trends, Forecast by 2017 – 2024

1 © 2016 Global Market Insights, Inc. USA. All Rights Res...
Author: Juee Kate
0 downloads 2 Views

1 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Fuel Cell Market size worth $25.5bn by 2024 Pharmacovigilance Market Trends, Opportunities, Market Players 2024: Global Market Insights Inc.

2 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  Global Market Insights, Inc. says Worldwide Pharmacovigilance Market having had a revenue of USD 3 billion in 2015, is predicted to surpass a revenue collection of USD 8 billion by 2024.  The crucial need to monitor the efficiency and aftereffects of drugs will drive pharmacovigilance market.  The field of pharmacovigilance globally represents the picture of drug effectiveness, safety, and associated risk detection.  Most of the pharmaceutical and biotechnology firms are adopting these services to maintain and manage clinical trial data, which will favorably influence pharmacovigilance market share from in-house companies, which generated a revenue of USD 1.5 billion in 2015 and is likely to increase two-fold by 2024.  Companies established in the developed countries often outsource these services, considering the operational cost reduction effectiveness and quality. Key Insights from Pharmacovigilance Market :

3 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com  The notable business participants in pharmacovigilance market are Accenture, Boehringer Ingelheim, Covance, PAREXEL, Bristol-Myers Squibb, Quintiles, Cognizant Technology Solutions Corporation, United BioSource, and ICON.  Contract outsourcing covered more than 50% of the revenue share of the service provider segment in pharmacovigilance industry in 2015 and will exceed a revenue collection of USD 4.8 billion by 2024.  Asia Pacific pharmacovigilance market having had a revenue of USD 835 million in 2015, will surpass a revenue collection of USD 2.4 billion by 2024.  U.S. pharmacovigilance industry collected a revenue of USD 1 billion in 2015 and will exceed a revenue generation of USD 2.5 billion by 2024 with an annual growth rate of 10.7% over the period of 2016 to 2024.  Industry giants are engaged in strategic partnerships with research organizations to enhance the effectiveness of the product. Mergers & acquisitions is a major growth strategy adopted by the market players to comply with competitiveness of the business. Continued...

4 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com U.S. Pharmacovigilance Market size, by service provider, 2012- 2024 (USD Million)

5 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Browse Full Market Research Report On PharmacovigilanceMarket @ http://bit.ly/2AQAXaJ http://bit.ly/2AQAXaJ Request for a Sample of this Research Report @ https://www.gminsights.com/request-sample/detail/853 https://www.gminsights.com/request-sample/detail/853 https://www.gminsights.com/request-sample/detail/49

6 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary Sources 1.2.2. Secondary Sources Chapter 2. Executive Summary 2.1. Pharmacovigilance industry 3600 synopsis, 2012 - 2024 2.1.1. Business trends 2.1.2. End user trends 2.1.3. Regional trends Table of Content:

7 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Chapter 3. Pharmacovigilance Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2024 3.3. Industry impact forces 3.3.1. Growth drivers 3.3.1.1. Increase in adoption rate of outsourcing services 3.3.1.2. Increasing consumption of drugs 3.3.1.3. Rise in adverse drug reactions (ADR) and drug toxicity 3.3.2. Industry pitfalls & challenges 3.3.2.1. Dearth of availability of skilled personnel 3.3.2.2. High risk associated with data security 3.4. Growth potential analysis 3.4.1. New business models 3.5. Porter’s analysis Table of Content:

8 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com 3.6. Regulatory Landscape 3.7. Pharmacovigilance Reporting system 3.8. Company market share analysis, 2015 3.8.1. Strategy dashboard 3.9. PESTEL analysis Table of Content:

9 © 2016 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com Stay In Touch Website: www.gminsights.comwww.gminsights.com Social Media: